Skip to main content
OpenTrials

Clinical trial condition

HER2 Positive Metastatic Breast Cancers

Explore clinical trials studying HER2 Positive Metastatic Breast Cancers. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

HER2 Positive Metastatic Breast Cancers trial results

Completed

A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer

NCT02025192

Conditions
Breast Diseases, Breast Neoplasms, HER2 Positive Metastatic Breast Cancers, +4 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Providence Cancer Center Portland, Oregon, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions